Analysen von Gbola Amusa
| 09.04.14 | Rio Tinto buy | UBS AG | |
| 03.12.12 | Sanofi buy | UBS AG | |
| 02.11.12 | GSK neutral | UBS AG | |
| 01.11.12 | GSK neutral | UBS AG | |
| 18.10.12 | GSK neutral | UBS AG | |
| 12.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | Novartis buy | UBS AG | |
| 27.09.12 | Roche neutral | UBS AG | |
|
Werbung
|
|||
| 21.09.12 | Novo Nordisk buy | UBS AG | |
| 19.09.12 | AstraZeneca buy | UBS AG | |
| 06.09.12 | GSK neutral | UBS AG | |
| 28.08.12 | GSK neutral | UBS AG | |
| 27.07.12 | GSK buy | UBS AG | |
| 27.07.12 | AstraZeneca buy | UBS AG | |
| 26.07.12 | GSK buy | UBS AG | |
| 17.07.12 | Novartis buy | UBS AG | |
| 16.07.12 | AstraZeneca buy | UBS AG | |
| 10.07.12 | GSK buy | UBS AG | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 25.06.12 | Novartis buy | UBS AG | |
| 18.06.12 | Merck buy | UBS AG | |
| 08.06.12 | AstraZeneca buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 18.05.12 | AstraZeneca buy | UBS AG | |
| 04.05.12 | AstraZeneca buy | UBS AG | |
| 12.04.12 | Microsoft buy | UBS AG | |
| 30.03.12 | AstraZeneca buy | UBS AG | |
| 23.03.12 | Sanofi buy | UBS AG | |
| 23.03.12 | AstraZeneca buy | UBS AG | |
| 09.03.12 | Novartis buy | UBS AG | |
| 08.02.12 | GSK buy | UBS AG | |
| 17.10.11 | AstraZeneca buy | UBS AG | |
| 11.10.11 | AstraZeneca buy | UBS AG | |
| 06.10.11 | Novartis buy | UBS AG | |
| 05.09.11 | Sanofi buy | UBS AG | |
| 29.07.11 | AstraZeneca buy | UBS AG | |
| 28.07.11 | GSK buy | UBS AG | |
| 27.07.11 | GSK buy | UBS AG | |
| 20.07.11 | Sanofi buy | UBS AG | |
| 20.07.11 | AstraZeneca buy | UBS AG | |
| 20.07.11 | AstraZeneca buy | UBS AG | |
| 19.07.11 | GSK buy | UBS AG | |
| 18.07.11 | AstraZeneca buy | UBS AG | |
| 18.07.11 | Novartis buy | UBS AG | |
| 30.06.11 | AstraZeneca buy | UBS AG | |
| 27.06.11 | AstraZeneca buy | UBS AG | |
| 20.06.11 | AstraZeneca buy | UBS AG | |
| 08.06.11 | GSK buy | UBS AG | |
| 03.06.11 | Merck neutral | UBS AG | |
| 12.05.11 | AstraZeneca buy | UBS AG | |